What Happened?
Oldwick, New Jersey-based Provention Bio Appointed Mick Nucum as Director, Information Technology
Date of management change: November 11, 2020
Oldwick, New Jersey-based Provention Bio Appointed Mick Nucum as Director, Information Technology
Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. -We seek technologies or targets designed to predict, preempt or intervene before immune disease begins, re-appears or progresses. -We are creating a new biopharmaceutical category for autoimmunity. We leverage a transformational drug development strategy that sources, repositions and advances candidates that: -Target the interception or prevention of immune-mediated disease -Have been underdeveloped or deprioritized because of insufficient clinical trial efficacy or for strategic reasons -Have demonstrated proof-of-mechanism by preventing or intercepting immunopathologic pathways We believe that our deep understanding of immune-mediated pathophysiology, experience in translational medicine, and expertise in the design of rapid go/no-go clinical trials enables us to identify and evaluate potential therapeutic candidates for acquisition or in-licensing.
Mick Nucum is Director, Information Technology at Provention Bio. Previously, Mick held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Hale Roger, Thomas Kate, Jog Mandar, Palmarozzo Joseph, Patanaik Rajesh, Markilinski Steven, Mohiuddin Amaan, West Dana, Gandhi Vinay, Brandt Larry, Argenti Marco
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.